Cargando…

Pembrolizumab‐induced myasthenia gravis with myositis in a patient with lung cancer

In the new era of cancer immunotherapy, clinical research has uncovered diverse and unpredictable immune‐related adverse events. Here, we report the first case of pembrolizumab‐induced myasthenia gravis (MG) and myositis in a patient with lung cancer. The patient developed symptoms after the second...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hibino, Makoto, Maeda, Kazunari, Horiuchi, Shigeto, Fukuda, Minoru, Kondo, Tetsuri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2018
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079932/ https://www.ncbi.nlm.nih.gov/pubmed/30094028 http://dx.doi.org/10.1002/rcr2.355

Ejemplares similares

Pulmonary lymphangitic carcinomatosis with ground‐glass opacities as presentation of prostate cancer
por: Hibino, Makoto, et al.
Publicado: (2018)

Diffusion-weighted magnetic resonance imaging-directed biopsy of a metastatic bone tumor: Lung adenocarcinoma with ALK rearrangement
por: Hibino, Makoto, et al.
Publicado: (2018)

Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Todo, Maki, et al.
Publicado: (2019)

Pembrolizumab-induced Myasthenia Gravis Relapse after Immunosuppressive Therapy
por: Oshima, Yuki, et al.
Publicado: (2022)

Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report
por: Tian, Chia-Yi, et al.
Publicado: (2021)

Pembrolizumab-Induced Myasthenia Gravis and Myositis: Literature Review on Neurological Toxicities of Programmed Death Protein 1 Inhibitors
por: Schwab, Alfred, et al.
Publicado: (2022)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report
por: Cham, Jason, et al.
Publicado: (2021)

Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Tomisaki, Ikko
Publicado: (2019)

Antibody Responses to the BNT162b2 mRNA Vaccine in Healthcare Workers in a General Hospital in Japan: A Comparison of Two Assays for Anti-spike Protein Immunoglobulin G
por: Hibino, Makoto, et al.
Publicado: (2021)

A Case of Pembrolizumab-Induced Myasthenia Gravis
por: Kosick, Thomas I, et al.
Publicado: (2023)

Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy
por: Onda, Asako, et al.
Publicado: (2019)

Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis
por: Ishii, Akiko, et al.
Publicado: (2020)

Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023)

Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis
por: Fukasawa, Yoko, et al.
Publicado: (2017)

Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021)

Dacryoadenitis with Ptosis and Diplopia as the Initial Presentation of Granulomatosis with Polyangiitis
por: Hibino, Makoto, et al.
Publicado: (2017)

Interstitial Pneumonia Associated with the Influenza Vaccine: A Report of Two Cases
por: Hibino, Makoto, et al.
Publicado: (2017)

Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma
por: Xing, Qian, et al.
Publicado: (2020)

Nivolumab-related myasthenia gravis with myositis requiring prolonged mechanical ventilation: a case report
por: Saishu, Yumi, et al.
Publicado: (2022)

Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis
por: Tozuka, Takehiro, et al.
Publicado: (2018)

Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan
por: Hibino, Makoto, et al.
Publicado: (2022)

Granulomatous Myositis Associated with Myasthenia Gravis: A Rare Case
por: Iqbal, Shumaila M, et al.
Publicado: (2019)

Pembrolizumab-Induced Myasthenia Gravis and Peripheral Neuropathy: A Case Series
por: McCormack, Sean M, et al.
Publicado: (2023)

Pembrolizumab-Induced Myasthenia Gravis: A Case Report and Review of the Literature
por: Eglenen Polat, Buse, et al.
Publicado: (2023)

Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report
por: Kamo, Hikaru, et al.
Publicado: (2019)

Anti-Kv1.4 Antibody Without Myasthenia Gravis: A Rare Cause of Autoimmune Myocarditis and Myositis
por: Kuyama, Naoto, et al.
Publicado: (2023)

A case report of nivolumab-induced myasthenia gravis and myositis in a metastatic renal cell carcinoma patient
por: Nakanishi, Shotaro, et al.
Publicado: (2019)

Myasthenia gravis and concurrent myositis following PD-L1 checkpoint inhibitor for non-small cell lung cancer
por: Phua, Chun Seng, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit
por: Deharo, François, et al.
Publicado: (2022)

Anti-Kv1.4 Antibody-positive Nivolumab-induced Myasthenia Gravis and Myositis Presenting with Bilateral Ptosis and Demonstrating Different Pathophysiologies
por: Kitazaki, Yuki, et al.
Publicado: (2023)

Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune–Biological Evaluation and Case Report
por: Botta, Cirino, et al.
Publicado: (2021)

A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis
por: Stefanou, M. I., et al.
Publicado: (2016)

Successful Lung Transplantation in a Patient with Myasthenia Gravis
por: Kim, Kangmin, et al.
Publicado: (2017)

Castleman's Disease with Myasthenia Gravis
por: Lee, Sang-Kwon, et al.
Publicado: (2012)

Multiple Thymoma with Myasthenia Gravis
por: Seo, Dong Hyun, et al.
Publicado: (2017)

Giant cell myositis associated with concurrent myasthenia gravis: a case-based review of the literature
por: Scangarello, Frank A, et al.
Publicado: (2021)

Myositis associated to COVID-19 mimics an acute exacerbation in myasthenia gravis patient
por: De Martino, Antonio, et al.
Publicado: (2021)

Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma
por: Virgen, Cesar A, et al.
Publicado: (2023)

Seropositive Myasthenia Gravis Associated with Small-Cell Lung Carcinoma
por: Ohira, Masayuki, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_epu11hgf0oqk078o2r15rol98v